Gavin Wu

Mr. Gavin Wu

Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
GWGavin Wu
Gavin Wu
NBNojan Bajestani
Nojan Bajestani
NPNooruddin Pracha
Nooruddin Pracha
CCCindy Chen
Cindy Chen
MMMina S Makary
Mina S Makary
Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, with prognosis and treatment outcomes that are significantly influenced by the stage at diagnosis. Early detection through regular surveillance is crucial for improving patient outcomes, especially in high-risk groups such as those with cirrhosis or chronic hepatitis B. Geographic variations in HCC risk factors, including viral hepatitis and non-alcoholic fatty liver disease (NAFLD), have led to the development of different international surveillance guidelines. This review aims to compare and evaluate the surveillance strategies proposed by the Asian Pacific Association for the Study of the Liver (APASL), the American Association for the Study of Liver Diseases (AASLD), and the European Association for the Study of the Liver and European Organization for Research and Treatment of Cancer (EASL–EORTC). Methods: The review examined and compared major international guidelines on HCC surveillance, focusing on patient selection, imaging modalities, and the integration of biomarkers. We also explored recent advancements in screening techniques, including artificial intelligence and emerging biomarkers, to identify future directions for improving surveillance strategies. Results: Our analysis identified key differences in the guidelines, particularly in imaging modality preferences and the use of biomarkers for early detection. While all guidelines place emphasis on high-risk populations, the inclusion criteria and surveillance intervals vary. Additionally, novel technologies such as artificial intelligence show potential to enhance the accuracy and efficiency of HCC detection. Conclusions: This review highlights the need to harmonize the international guidelines, particularly in regard to patients with non-cirrhotic NAFLD who remain under-represented in current surveillance protocols. Future research should focus on integrating emerging technologies and biomarkers to improve early detection and overall patient outcomes.

27 June 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
NBNojan Bajestani
Nojan Bajestani
GWGavin Wu
Gavin Wu
AHAhmed Hussein
Ahmed Hussein
MMMina S Makary
Mina S Makary
More than 800,000 people worldwide are diagnosed with HCC (hepatocellular carcinoma) each year, with approximately 700,000 deaths alone occurring in that same year. Treatment of HCC presents complex therapeutic challenges, particularly in intermediate and advanced stages. LRTs such as transarterial chemoembolization (TACE) and ablations have been the mainstay treatment for early to intermediate-stage HCC, and systemic therapies are used to treat intermediate-late-stage HCC. However, novel literature describing combining LRT with systemic therapies has shown promising results. This review explores recent advances in both liver-directed techniques for hepatocellular carcinoma, including bland transarterial embolization, chemoembolization, radioembolization, and ablative therapies in conjunction as well as with systemic therapies, with a focus on combination therapies, patient selection, procedural technique, periprocedural management, and outcomes. Our findings suggest that LRT combined with systemic therapies is a viable strategy for improving progression-free survival and time to progression for patients with intermediate-to-late-stage HCC. However, further investigation is required to refine treatment protocols and define patient cohorts that would benefit the most.

28 October 2025 in CVIR Endovascular
Verified
Journal Article
Open access
PDF file
GWGavin Wu
Gavin Wu
DSDavid S. Shin
David S. Shin
NNNeha Naidoo
Neha Naidoo
SLSpencer B. Lewis
Spencer B. Lewis
JCJeffrey Forris Beecham Chick
Jeffrey Forris Beecham Chick
MMMina S. Makary
Mina S. Makary

11 June 2025 in Journal of Clinical Densitometry
Verified
Journal Article
Open access
GSGary K. Schneider
Gary K. Schneider
JBJason A. Benedict
Jason A. Benedict
JMJennifer Matsui
Jennifer Matsui
GWGavin Wu
Gavin Wu
MRMichael Ruesch
Michael Ruesch
SISteven W. Ing
Steven W. Ing
Radiation therapy (RT), a standard treatment modality for locally advanced anorectal cancer, may be followed by pelvic fractures, but there are currently no formal recommendations to evaluate bone health prior to RT. Recent studies have demonstrated CT attenuation measurement of lumbar vertebrae as a surrogate marker of bone mineral density (BMD). In this single-institution retrospective cohort analysis of patients with anorectal carcinoma treated with RT, we assess lumbar and sacral CT attenuation before and after RT. CT scans of 302 patients with at least one pre- and post- RT CT scan including all of L1, L3, L5, and sacrum were reviewed, and CT attenuation measured at each level. All CT scans were obtained for either cancer surveillance or other medically indicated reason. CT attenuation measurements were adjusted for presence of IV contrast and nonstandard CT tube voltage. Prior to RT, mean bone attenuation at L1, L3, L5, and sacrum were 158.4, 151.1, 157.8, and 231.0 HU respectively. Three months post-RT, L1 and L3 had mean differences of +1.7 (+1.1 %) and -7.7 (-5.1 %) HU, respectively, while L5 and sacrum had mean differences of -48.8 (-31.0 %) and -65.9 (-28.6 %) HU, respectively. There was little to no evidence of further decrease at any vertebral level beyond three months after RT, nor was there evidence for increase in HU beyond three months, by which time RT courses were completed. This suggests that bone loss from RT is associated with proximity to the radiation field and the majority of the observed decline occurs within the first three months following the start of RT.

14 March 2026 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
GWGavin Wu
Gavin Wu
JCJeffrey Forris Beecham Chick
Jeffrey Forris Beecham Chick
DSDavid S. Shin
David S. Shin
EMEric J. Monroe
Eric J. Monroe
RARohit V. Anand
Rohit V. Anand
MMMina S. Makary
Mina S. Makary

1 May 2026 in CVIR Endovascular
Verified
Journal Article
Open access
PDF file
GWGavin Wu
Gavin Wu
JCJeffrey Forris Beecham Chick
Jeffrey Forris Beecham Chick
AGAdlai Grayson
Adlai Grayson
AJArthie Jeyakumar
Arthie Jeyakumar
AKAndrew G. Kim
Andrew G. Kim
MMMina S. Makary
Mina S. Makary
Background: Procedures performed after-hours have been associated with worse outcomes in several procedural specialties. Data examining the relationship between procedure timing and adverse event severity in interventional radiology remain limited. This study retrospectively evaluated adverse events reviewed at interventional radiology morbidity and mortality conferences to assess whether procedure timing was associated with differences in adverse event severity and quality-of-care assessment. Results: A total of 547 adverse events occurring across four affiliated hospital sites were included. The cohort comprised 341 males and 206 females with a mean age of 56.2 years. Vascular procedures accounted for 369 events (67.5%), and non-vascular procedures accounted for 178 events (32.5%). Most adverse events occurred during weekday daytime hours ( n = 459, 83.9%), followed by weekday after-hours ( n = 50, 9.1%) and weekend periods ( n = 38, 6.9%). Compared with weekday daytime procedures, a greater proportion of adverse events resulting in death occurred during weekday after-hours and on weekends, as reflected by a higher proportion of Society of Interventional Radiology class F events and Harm Score 9 outcomes ( p < 0.001). In contrast, no significant difference in Quality Control System scores was observed across procedure timing categories ( p = 0.73). Conclusions: Among adverse events reviewed at interventional radiology morbidity and mortality conferences, procedures performed during weekday after-hours and weekend periods were associated with greater adverse event severity, while quality-of-care assessments did not differ by procedure timing. These findings describe patterns within morbidity and mortality-reviewed complications and do not estimate complication rates or population-level risk by procedure timing. The absence of variation in Quality Control System scores supports the hypothesis that observed differences in severity may reflect patient acuity and procedural urgency rather than differences in procedural quality.